Sitero is a leading global provider of Clinical, Drug Safety and Review services serving pharmaceutical, biotechnology, and medical device companies.
Our team of experts brings a comprehensive portfolio of clinical research solutions, life science consulting, R&D technology, pharmacovigilance, and IRB/IBC solutions to help deliver the best possible outcome for our clients trials and their patients. Our end-to-end global clinical services and technology solutions are powered by a team with an unwavering dedication to serving clinical research and patients around the world.
As President, David heads Sitero’s daily operations and is responsible for achieving the company’s short and long-term goals and objectives. Prior to joining the Sitero team, David played various leadership roles in the Pharmaceutical and Life Sciences technology space, most recently as the SVP, Global Professional Services as ArisGlobal where he was a member of the Executive Team and played a key role in the successful acquisition by Nordic Capital.
We focus on innovative, technology enabled solutions that allow our clients to focus on their core strengths.
Chief Technology Officer & President APAC
Chief Commercial Officer
As Chief Commercial Officer, Jeff is responsible for the global commercial sales team and go to market strategies across the portfolio of Sitero’s technologies and services. Jeff brings over 30 years of experience in commercial planning, global business development, and scaling organizations in the healthcare and life sciences industry. Previously Jeff was President at J-Boys Consulting where he provided strategic advice to biopharmaceutical, CRO, and investment companies. Prior to that, he was a Healthcare Advisor at Warburg Pincus where he helped them carve out the Pharma Intelligence business of Informa, PLC, and rebrand as Citeline in June 2022. Jeff has also served in executive and commercial leadership roles at Clarivate Analytics, ConnectiveRx, Parexel, Liquent, Thomson Reuters, Rogers Medical Intelligence Solutions, and started his career at Stuart Pharmaceuticals (Astra Zeneca). He and his family reside outside of Philadelphia.
SVP, Global Delivery & Customer Success
VP, IBC & Biosafety Services
Dr. Ziegler is responsible for leading the Biosafety and IBC services at Sitero. Sarah was previously the Deputy Director of the National Bio and Agro-Defense Facility (NBAF) with the USDA where she supervised laboratory operations and Biorisk management. Sarah is an ABSA certified biosafety professional and is passionate about ensuring the safety of workers and the community during biomedical research. She has previously served as an IBC chair, Biosafety Officer and Responsible Official for multiple research institutions. She has also consulted on projects as an SME for Select Agents, Biorisk Management, facility design and Laboratory Operations. Sarah received her Ph.D. from the University of Texas Medical Branch in Biomedical Science and was a Post-doctoral Fellow in the National Biosafety and Biocontainment Training Program (NBBTP).
VP, Finance & Accounting
Senior Director, Drug Safety
Dipanjan Chaudhuri has been part of the Drug Safety industry for more than a decade and a half and was associated with some of the leading CROs in his previous roles leading multiple accounts ranging from smaller biotech companies to large pharma. Dipanjan brings a wealth of experience in managing ICSR services (both post marketing and clinical), aggregate reporting, risk management, client relations, and overall account management. Based out of Bengaluru, India, Dipanjan is responsible for leading the Drug Safety services here at Sitero.
Director, Clinical Drug Safety
Manager, Finance & Accounting